SCRI Oncology Partners /ID# 278353 — Nashville, Tennessee

SCRI Oncology Partners /ID# 278353 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Oncology Partners /ID# 278353 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Oncology Partners /ID# 278353?

SCRI Oncology Partners /ID# 278353 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Oncology Partners /ID# 278353 conducted?

SCRI Oncology Partners /ID# 278353 has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma.

Is SCRI Oncology Partners /ID# 278353 accredited by Crixeo Health?

SCRI Oncology Partners /ID# 278353 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Oncology Partners /ID# 278353?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.